tm logo
AZEMIDITE
Live/Registered
REGISTERED

on 29 Oct 2024

Last Applicant/ Owned by

Economic and Technological Development Zone Tianjin City

CN

Serial Number

79368347 filed on 23rd Feb 2023

Registration Number

7546656 registered on 29th Oct 2024

in the Principal Register

Correspondent Address

Zhi Dong

Zhi Dong HSML, P. C.

Minneapolis, MN 55402

United States

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

AZEMIDITE

Scientific laboratory services; scientific research; technical writing; technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; quality control for others; chemistry services, namely, chemistry consultation, research in the field of chemistry; chemical research and analysis; development and testing of chemical production methods; biochemical resear Read More

Classification Information


Class [042]
Computer & Software Services & Scientific Services


Scientific laboratory services; scientific research; technical writing; technological research in the field of pharmaceutical manufacturing processes and pharmaceutical studies; quality control for others; chemistry services, namely, chemistry consultation, research in the field of chemistry; chemical research and analysis; development and testing of chemical production methods; biochemical research and development; chemistry consultation


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [040]
Treatment & Processing of Materials Services


Custom assembling of materials for others, namely, custom manufacture of industrial chemicals, pharmaceuticals; providing information relating to material treatment; metal treating; rental of machines and apparatus for processing food; typesetting; recycling of chemicals; processing of chemical reagents for use in manufacture; rental of chemical processing machines; custom manufacturing of make-up


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [005]
Pharmaceutical Products


Medicines for humans for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemico-pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; vaccines; drugs for medical purposes, namely, pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biological preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disordersand rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for pharmaceutical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; chemical preparations for medical purposes for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; diagnostic biomarker reagents for medical purposes; crude drugs being pharmaceutical preparations for the treatment of cardiovascular diseases, metabolic diseases, liver diseases, genetic disorders and rare ocular, respiratory, gastrointestinal, cerebral diseases; biochemical medicines, namely, antidepressants, appetite suppressants, cardiovascular drugs, antitumor drugs and hypoglycemic drugs; chemical reagents for medical or veterinary purposes; diagnostic preparations for medical purposes; dietetic substances adapted for medical use, namely, dietary supplements and dietetic foods adapted for medical use; depuratives for the body; veterinary preparations for the treatment of gastrointestinal diseases, cardiovascular diseases, metabolic diseases, and liver diseases; pesticides; disinfectant wipes; dressings, medical; composite materials for dental purposes; diapers for pets


First Use Date in General

N/A

First Use Date in Commerce

N/A

Class [001]
Chemical Products


Glucosides being chemicals for industrial purposes; carbonic hydrates; polymer resins, unprocessed; artificial resins, unprocessed; chemical preparations in the nature of ion-exchange resins; enzymes for industrial purposes; enzymes for the food industry; biochemical catalysts; catalysts for chemical processes; industrial chemicals; chemical preparations for scientific purposes, other than for medical or veterinary use; chemical reagents, other than for medical or veterinary purposes; chemical substances for analyses in laboratories, other than for medical or veterinary purposes; chemical preparations for analyses in laboratories, other than for medical or veterinary purposes; cryogenic preparations in solid, liquid or gas state for use in chilling and freezing; diagnostic preparations, other than for medical or veterinary purposes


First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details


Serial Number

No 79368347

Mark Type

No Service Mark

Attorney Docket Number

No 20700.0414US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
29th Oct 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
29th Oct 2024REGISTERED-PRINCIPAL REGISTER
12th Oct 2024NOTIFICATION OF POSSIBLE OPPOSITION - PROCESSED BY IB
25th Sep 2024NOTIFICATION OF POSSIBLE OPPOSITION CREATED, TO BE SENT TO IB
25th Sep 2024NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13th Aug 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13th Aug 2024PUBLISHED FOR OPPOSITION
24th Jul 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
02th Jul 2024EXAMINERS AMENDMENT E-MAILED
02th Jul 2024EXAMINERS AMENDMENT -WRITTEN